Skip to content

The Effect of Remote Ischemic Preconditioning on Diastolic Function in Coronary Artery Bypass Surgery Between Diabetic and Non-Diabetic Patients

Efficacy of Remote Ischemic Preconditioning on Diastolic Function in Coronary Artery Bypass Surgery: A Randomized Controlled Study Comparing Diabetic and Non-Diabetic Patients

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06841757
Enrollment
40
Registered
2025-02-24
Start date
2025-01-01
Completion date
2025-07-31
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Diabetes Mellitus, Diastolic Function

Keywords

Coronary artery bypass surgery, Diastolic function, Remote ischemic preconditioning

Brief summary

This randomized controlled study aims to evaluate the effects of Remote Ischemic Preconditioning (RIPC) on diastolic function in patients undergoing coronary artery bypass grafting (CABG). The study will compare diabetic and non-diabetic patients to determine whether RIPC improves myocardial relaxation and reduces diastolic dysfunction, as assessed by the E/e' ratio at multiple time points during the surgery.

Interventions

BEHAVIORALRemote ischemic preconditioning

Patients will undergo Remote Ischemic Preconditioning using a blood pressure cuff inflated on the upper limb to induce ischemia and reperfusion, 40 mmHg above systolic pressure. The procedure will involve 3 cycles of inflation (5 minutes each) and deflation (5 minutes each) post intubation

Sponsors

Alzahraa Khalil Marie
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All adult patients scheduled for elective isolated on-pump CABG surgery for two- to three-vessel coronary artery disease. * Both males and females will be included. * In the diabetic groups: Type II diabetes currently requiring and adhering to insulin therapy for at least the past 3 months * During cardiopulmonary bypass, the temperature will range from 28-33°C using an esophageal temperature probe. * Antegrade warm cardioplegia will be given by the cardiovascular perfusionist. * Baseline diastolic function will be obtained preoperatively using transthoracic echocardiography done within the six months prior to the surgery

Exclusion criteria

* Combined CABG and valve surgery, emergency CABG. * Type I diabetes, Type 2 diabetes managed with oral hypoglycemic agents without insulin in the past 3 months * Peripheral vascular disease (PVD) affecting the upper limbs. * Acute coronary syndrome (ACS); acute or recent myocardial infarction. * Left ventricular ejection fraction ≤30%. * Serious pulmonary disease necessitating oxygen supplementation or mechanical ventilation. * Renal failure, defined as eGFR \< 30 mL/min/1.73 m² or requiring renal replacement therapy (dialysis). * Liver failure, including Child-Pugh Class B or C cirrhosis, severe hepatocellular dysfunction, or listed for liver transplantation.

Design outcomes

Primary

MeasureTime frameDescription
E/e' Ratio (Diastolic Function)T1: immediately after anesthesia induction and intubation (baseline) T2: Immediately before cardiopulmonary bypass (CPB) T3: 10 minutes after reperfusion and separation from CPB T4: 45 minutes after separation from CPB and before transfer to the ICUEchocardiography (Tissue Doppler Imaging) will be used to measure the E/e' ratio, a reliable parameter for assessing left ventricular filling pressure and diastolic function. This is the primary method to evaluate the effect of Remote Ischemic Preconditioning (RIPC) on diastolic function in both diabetic and non-diabetic patients undergoing CABG.

Secondary

MeasureTime frameDescription
Deceleration Time (DT)T1: immediately after anesthesia induction and intubation (baseline) T2: Immediately before cardiopulmonary bypass (CPB) T3: 10 minutes after reperfusion and separation from CPB T4: 45 minutes after separation from CPB and before transfer to the ICU
Cardiac Troponin LevelsEvaluate cardiac troponin levels postoperatively after 24 hours as a marker of myocardial injury
Mitral Inflow Velocities(E/A Ratio)T1: immediately after anesthesia induction and intubation (baseline) T2: Immediately before cardiopulmonary bypass (CPB) T3: 10 minutes after reperfusion and separation from CPB T4: 45 minutes after separation from CPB and before transfer to the ICUUsing TEE to measure E/A ratio
Inotropic Support:During surgeryUsage and dose.
LVEFCompare between start and end of surgeryEjection fraction
Systolic and diastolic Blood pressureT1: immediately after anesthesia induction and intubation (baseline) T2: Immediately before cardiopulmonary bypass (CPB) T3: 10 minutes after reperfusion and separation from CPB T4: 45 minutes after separation from CPB and before transfer to the ICU

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026